A detailed history of Royal Capital Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Royal Capital Wealth Management, LLC holds 3,136 shares of AMGN stock, worth $823,670. This represents 0.73% of its overall portfolio holdings.

Number of Shares
3,136
Previous 3,263 3.89%
Holding current value
$823,670
Previous $1.02 Million 0.88%
% of portfolio
0.73%
Previous 0.78%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $39,291 - $42,847
-127 Reduced 3.89%
3,136 $1.01 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $64,636 - $78,550
-246 Reduced 7.01%
3,263 $1.02 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $572,961 - $691,637
-2,131 Reduced 37.78%
3,509 $997,000
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $36,053 - $40,672
141 Added 2.56%
5,640 $1.62 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $27,331 - $33,932
-125 Reduced 2.22%
5,499 $1.48 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $22,926 - $27,110
-107 Reduced 1.87%
5,624 $1.25 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $39,513 - $48,160
-175 Reduced 2.96%
5,731 $1.39 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $8,245 - $10,476
-36 Reduced 0.61%
5,906 $1.55 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $3,591 - $4,050
16 Added 0.27%
5,942 $1.34 Million
Q2 2022

Aug 16, 2022

SELL
$230.71 - $256.74 $10,381 - $11,553
-45 Reduced 0.75%
5,926 $1.44 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $2,850 - $3,153
-13 Reduced 0.22%
5,971 $1.44 Million
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $1.19 Million - $1.36 Million
5,984 New
5,984 $1.35 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Royal Capital Wealth Management, LLC Portfolio

Follow Royal Capital Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Capital Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Capital Wealth Management, LLC with notifications on news.